IPP Bureau
Takara Bio Europe unveils new large-scale NGS profiling system and chemistries
By IPP Bureau - September 27, 2024
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
Torrent Pharmaceuticals refutes claims of Shelcal 500 allegedly failing CDSCO quality test
By IPP Bureau - September 27, 2024
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
Sun Pharma presents clinical efficacy and safety data in severe dermatological conditions at 2024 EADV Congress
By IPP Bureau - September 27, 2024
The company will also share results in two additional posters for deuruxolitinib
Krsnaa Diagnostics acquires stake in Apulki Healthcare
By IPP Bureau - September 27, 2024
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Avient expands healthcare TPU manufacturing in China
By IPP Bureau - September 27, 2024
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
India highlights need for global cooperation to address AMR threat at UNGA
By IPP Bureau - September 27, 2024
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Rockwell study highlights need for highly skilled workforce for life sciences
By IPP Bureau - September 27, 2024
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Zydus and CSIR-CDRI Lucknow to develop drug for CKD induced Osteoporosis
By IPP Bureau - September 27, 2024
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Alkem denies claims of Pan-D, Clavam 625 batches being substandard quality
By IPP Bureau - September 27, 2024
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Alembic receives USFDA final approval for Paliperidone ER tablets
By IPP Bureau - September 27, 2024
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
Briefs: Krsnaa Diagnostics and Anuh Pharma
By IPP Bureau - September 27, 2024
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
USV launches Q rite tablets for treatment of rare aprhythmia in heart patients
By IPP Bureau - September 27, 2024
Quinidine Sulphate helps manage rare irregular heartbeat conditions
Sanofi’s dupixent approved in the US as the first-ever biologic medicine for patients with COPD
By IPP Bureau - September 27, 2024
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
BlueRock Therapeutics’ investigational cell therapy bemdaneprocel for Parkinson’s disease shows positive data at 24-months
By IPP Bureau - September 27, 2024
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
